Detalhe da pesquisa
1.
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Breast Cancer Res Treat
; 198(3): 463-474, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790573
2.
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.
Br J Clin Pharmacol
; 89(7): 2283-2294, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854898
3.
Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended.
Eur J Cancer Care (Engl)
; 31(6): e13654, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866619
4.
Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for management.
Support Care Cancer
; 29(4): 1719-1722, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140247
5.
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Breast Cancer Res Treat
; 177(3): 659-667, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297647
6.
Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes.
Breast
; 67: 102-109, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709639
7.
HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.
Oncologist
; 16(10): 1469-78, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21964002
8.
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Breast
; 59: 144-156, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252822
9.
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109].
Breast
; 69: 424-427, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172498
10.
[Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy]. / Étude observationnelle du temps passé en hôpital de jour selon la voie d'administration (intraveineuse vs sous-cutanée) d'une thérapie ciblée.
Bull Cancer
; 104(10): 869-874, 2017 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-29032944